Alto Neuroscience (ANRO) Non-Current Assets (2023 - 2026)

Alto Neuroscience has reported Non-Current Assets for 4 years, with the latest figure at $7.1 million in Q1 2026.

• Quarterly Non-Current Assets fell 15.0% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.7 million (up 11.52% YoY) and the FY2025 annual result came in at $7.0 million, down 15.04% from the prior year.
• Non-Current Assets rose to $7.1 million in Q1 2026 per ANRO's latest filing, from $7.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $8.4 million in Q1 2025 and troughed at $1.2 million in Q4 2023.
• A 4-year average of $5.9 million and a median of $7.3 million in 2025 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets jumped 563.3% in 2024, then slipped 15.04% in 2025.
• Over 4 years, Non-Current Assets stood at $1.2 million in 2023, then surged by 563.3% to $8.2 million in 2024, then retreated by 15.04% to $7.0 million in 2025, then climbed by 2.32% to $7.1 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $7.1 million, $7.0 million, and $7.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.